Global Colorectal Cancer Diagnostics & Therapeutics Market Growth (Status and Outlook) 2023-2028

Report ID: 1201780 | Published Date: Jan 2025 | No. of Page: 124 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size 2017-2028
        2.1.2 Colorectal Cancer Diagnostics & Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Colorectal Cancer Diagnostics & Therapeutics Segment by Type
        2.2.1 Colorectal Cancer Diagnostics
        2.2.2 Colorectal Cancer Therapeutics
    2.3 Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
        2.3.1 Colorectal Cancer Diagnostics & Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2022)
    2.4 Colorectal Cancer Diagnostics & Therapeutics Segment by Application
        2.4.1 Hospitals
        2.4.2 Specialty Clinics
        2.4.3 Others
    2.5 Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
        2.5.1 Colorectal Cancer Diagnostics & Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2022)
3 Colorectal Cancer Diagnostics & Therapeutics Market Size by Player
    3.1 Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Players
        3.1.1 Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Players (2020-2022)
        3.1.2 Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Players (2020-2022)
    3.2 Global Colorectal Cancer Diagnostics & Therapeutics Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Colorectal Cancer Diagnostics & Therapeutics by Regions
    4.1 Colorectal Cancer Diagnostics & Therapeutics Market Size by Regions (2017-2022)
    4.2 Americas Colorectal Cancer Diagnostics & Therapeutics Market Size Growth (2017-2022)
    4.3 APAC Colorectal Cancer Diagnostics & Therapeutics Market Size Growth (2017-2022)
    4.4 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Growth (2017-2022)
    4.5 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022)
    5.2 Americas Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
    5.3 Americas Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2017-2022)
    6.2 APAC Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
    6.3 APAC Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Colorectal Cancer Diagnostics & Therapeutics by Country (2017-2022)
    7.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
    7.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics by Region (2017-2022)
    8.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
    8.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Colorectal Cancer Diagnostics & Therapeutics Market Forecast
    10.1 Global Colorectal Cancer Diagnostics & Therapeutics Forecast by Regions (2023-2028)
        10.1.1 Global Colorectal Cancer Diagnostics & Therapeutics Forecast by Regions (2023-2028)
        10.1.2 Americas Colorectal Cancer Diagnostics & Therapeutics Forecast
        10.1.3 APAC Colorectal Cancer Diagnostics & Therapeutics Forecast
        10.1.4 Europe Colorectal Cancer Diagnostics & Therapeutics Forecast
        10.1.5 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Forecast
    10.2 Americas Colorectal Cancer Diagnostics & Therapeutics Forecast by Country (2023-2028)
        10.2.1 United States Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.2.2 Canada Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.2.3 Mexico Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.2.4 Brazil Colorectal Cancer Diagnostics & Therapeutics Market Forecast
    10.3 APAC Colorectal Cancer Diagnostics & Therapeutics Forecast by Region (2023-2028)
        10.3.1 China Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.3.2 Japan Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.3.3 Korea Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.3.4 Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.3.5 India Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.3.6 Australia Colorectal Cancer Diagnostics & Therapeutics Market Forecast
    10.4 Europe Colorectal Cancer Diagnostics & Therapeutics Forecast by Country (2023-2028)
        10.4.1 Germany Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.4.2 France Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.4.3 UK Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.4.4 Italy Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.4.5 Russia Colorectal Cancer Diagnostics & Therapeutics Market Forecast
    10.5 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Forecast by Region (2023-2028)
        10.5.1 Egypt Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.5.2 South Africa Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.5.3 Israel Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.5.4 Turkey Colorectal Cancer Diagnostics & Therapeutics Market Forecast
        10.5.5 GCC Countries Colorectal Cancer Diagnostics & Therapeutics Market Forecast
    10.6 Global Colorectal Cancer Diagnostics & Therapeutics Forecast by Type (2023-2028)
    10.7 Global Colorectal Cancer Diagnostics & Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Biocept
        11.1.1 Biocept Company Information
        11.1.2 Biocept Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Biocept Main Business Overview
        11.1.5 Biocept Latest Developments
    11.2 Cancer Genetics
        11.2.1 Cancer Genetics Company Information
        11.2.2 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Cancer Genetics Main Business Overview
        11.2.5 Cancer Genetics Latest Developments
    11.3 Foundation Medicine
        11.3.1 Foundation Medicine Company Information
        11.3.2 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Foundation Medicine Main Business Overview
        11.3.5 Foundation Medicine Latest Developments
    11.4 Sysmex Corporation
        11.4.1 Sysmex Corporation Company Information
        11.4.2 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Sysmex Corporation Main Business Overview
        11.4.5 Sysmex Corporation Latest Developments
    11.5 Danaher Corporation
        11.5.1 Danaher Corporation Company Information
        11.5.2 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Danaher Corporation Main Business Overview
        11.5.5 Danaher Corporation Latest Developments
    11.6 Epigenomics
        11.6.1 Epigenomics Company Information
        11.6.2 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Epigenomics Main Business Overview
        11.6.5 Epigenomics Latest Developments
    11.7 Illumina
        11.7.1 Illumina Company Information
        11.7.2 Illumina Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Illumina Main Business Overview
        11.7.5 Illumina Latest Developments
    11.8 Rosetta Genomics
        11.8.1 Rosetta Genomics Company Information
        11.8.2 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Rosetta Genomics Main Business Overview
        11.8.5 Rosetta Genomics Latest Developments
    11.9 Exact Science Corporation
        11.9.1 Exact Science Corporation Company Information
        11.9.2 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Exact Science Corporation Main Business Overview
        11.9.5 Exact Science Corporation Latest Developments
    11.10 Pathway Genomics Corporation
        11.10.1 Pathway Genomics Corporation Company Information
        11.10.2 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Pathway Genomics Corporation Main Business Overview
        11.10.5 Pathway Genomics Corporation Latest Developments
    11.11 Taiho Pharma
        11.11.1 Taiho Pharma Company Information
        11.11.2 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Taiho Pharma Main Business Overview
        11.11.5 Taiho Pharma Latest Developments
    11.12 Merck KGaA
        11.12.1 Merck KGaA Company Information
        11.12.2 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Merck KGaA Main Business Overview
        11.12.5 Merck KGaA Latest Developments
    11.13 Amgen
        11.13.1 Amgen Company Information
        11.13.2 Amgen Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Amgen Main Business Overview
        11.13.5 Amgen Latest Developments
    11.14 Takeda
        11.14.1 Takeda Company Information
        11.14.2 Takeda Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Takeda Main Business Overview
        11.14.5 Takeda Latest Developments
    11.15 Roche
        11.15.1 Roche Company Information
        11.15.2 Roche Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Roche Main Business Overview
        11.15.5 Roche Latest Developments
    11.16 Eli Lilly
        11.16.1 Eli Lilly Company Information
        11.16.2 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Eli Lilly Main Business Overview
        11.16.5 Eli Lilly Latest Developments
    11.17 Sanofi
        11.17.1 Sanofi Company Information
        11.17.2 Sanofi Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Sanofi Main Business Overview
        11.17.5 Sanofi Latest Developments
    11.18 Regeneron
        11.18.1 Regeneron Company Information
        11.18.2 Regeneron Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 Regeneron Main Business Overview
        11.18.5 Regeneron Latest Developments
    11.19 Bayer
        11.19.1 Bayer Company Information
        11.19.2 Bayer Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.19.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 Bayer Main Business Overview
        11.19.5 Bayer Latest Developments
    11.20 Onyx
        11.20.1 Onyx Company Information
        11.20.2 Onyx Colorectal Cancer Diagnostics & Therapeutics Product Offered
        11.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.20.4 Onyx Main Business Overview
        11.20.5 Onyx Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Colorectal Cancer Diagnostics & Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Colorectal Cancer Diagnostics
    Table 3. Major Players of Colorectal Cancer Therapeutics
    Table 4. Colorectal Cancer Diagnostics & Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 6. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2022)
    Table 7. Colorectal Cancer Diagnostics & Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 9. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2022)
    Table 10. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Players (2020-2022) & ($ Millions)
    Table 11. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Player (2020-2022)
    Table 12. Colorectal Cancer Diagnostics & Therapeutics Key Players Head office and Products Offered
    Table 13. Colorectal Cancer Diagnostics & Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
    Table 17. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Regions (2017-2022)
    Table 18. Americas Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022) & ($ Millions)
    Table 19. Americas Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Country (2017-2022)
    Table 20. Americas Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 21. Americas Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2022)
    Table 22. Americas Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 23. Americas Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2022)
    Table 24. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2017-2022) & ($ Millions)
    Table 25. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Region (2017-2022)
    Table 26. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 27. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2022)
    Table 28. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 29. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2022)
    Table 30. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022) & ($ Millions)
    Table 31. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Country (2017-2022)
    Table 32. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 33. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2022)
    Table 34. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 35. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2022)
    Table 36. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2017-2022) & ($ Millions)
    Table 37. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Region (2017-2022)
    Table 38. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2022)
    Table 40. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2022)
    Table 42. Key Market Drivers & Growth Opportunities of Colorectal Cancer Diagnostics & Therapeutics
    Table 43. Key Market Challenges & Risks of Colorectal Cancer Diagnostics & Therapeutics
    Table 44. Key Industry Trends of Colorectal Cancer Diagnostics & Therapeutics
    Table 45. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 46. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
    Table 47. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 48. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share Forecast by Type (2023-2028)
    Table 49. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 50. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share Forecast by Application (2023-2028)
    Table 51. Biocept Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 52. Biocept Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 53. Biocept Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 54. Biocept Main Business
    Table 55. Biocept Latest Developments
    Table 56. Cancer Genetics Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 57. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 58. Cancer Genetics Main Business
    Table 59. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. Cancer Genetics Latest Developments
    Table 61. Foundation Medicine Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 62. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 63. Foundation Medicine Main Business
    Table 64. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 65. Foundation Medicine Latest Developments
    Table 66. Sysmex Corporation Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 67. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 68. Sysmex Corporation Main Business
    Table 69. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 70. Sysmex Corporation Latest Developments
    Table 71. Danaher Corporation Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 72. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 73. Danaher Corporation Main Business
    Table 74. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 75. Danaher Corporation Latest Developments
    Table 76. Epigenomics Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 77. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 78. Epigenomics Main Business
    Table 79. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 80. Epigenomics Latest Developments
    Table 81. Illumina Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 82. Illumina Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 83. Illumina Main Business
    Table 84. Illumina Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 85. Illumina Latest Developments
    Table 86. Rosetta Genomics Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 87. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 88. Rosetta Genomics Main Business
    Table 89. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 90. Rosetta Genomics Latest Developments
    Table 91. Exact Science Corporation Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 92. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 93. Exact Science Corporation Main Business
    Table 94. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 95. Exact Science Corporation Latest Developments
    Table 96. Pathway Genomics Corporation Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 97. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 98. Pathway Genomics Corporation Main Business
    Table 99. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 100. Pathway Genomics Corporation Latest Developments
    Table 101. Taiho Pharma Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 102. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 103. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 104. Taiho Pharma Main Business
    Table 105. Taiho Pharma Latest Developments
    Table 106. Merck KGaA Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 107. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 108. Merck KGaA Main Business
    Table 109. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 110. Merck KGaA Latest Developments
    Table 111. Amgen Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 112. Amgen Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 113. Amgen Main Business
    Table 114. Amgen Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 115. Amgen Latest Developments
    Table 116. Takeda Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 117. Takeda Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 118. Takeda Main Business
    Table 119. Takeda Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 120. Takeda Latest Developments
    Table 121. Roche Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 122. Roche Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 123. Roche Main Business
    Table 124. Roche Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 125. Roche Latest Developments
    Table 126. Eli Lilly Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 127. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 128. Eli Lilly Main Business
    Table 129. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 130. Eli Lilly Latest Developments
    Table 131. Sanofi Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 132. Sanofi Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 133. Sanofi Main Business
    Table 134. Sanofi Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 135. Sanofi Latest Developments
    Table 136. Regeneron Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 137. Regeneron Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 138. Regeneron Main Business
    Table 139. Regeneron Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 140. Regeneron Latest Developments
    Table 141. Bayer Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 142. Bayer Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 143. Bayer Main Business
    Table 144. Bayer Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 145. Bayer Latest Developments
    Table 146. Onyx Details, Company Type, Colorectal Cancer Diagnostics & Therapeutics Area Served and Its Competitors
    Table 147. Onyx Colorectal Cancer Diagnostics & Therapeutics Product Offered
    Table 148. Onyx Main Business
    Table 149. Onyx Colorectal Cancer Diagnostics & Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 150. Onyx Latest Developments
List of Figures
    Figure 1. Colorectal Cancer Diagnostics & Therapeutics Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type in 2021
    Figure 7. Colorectal Cancer Diagnostics & Therapeutics in Hospitals
    Figure 8. Global Colorectal Cancer Diagnostics & Therapeutics Market: Hospitals (2017-2022) & ($ Millions)
    Figure 9. Colorectal Cancer Diagnostics & Therapeutics in Specialty Clinics
    Figure 10. Global Colorectal Cancer Diagnostics & Therapeutics Market: Specialty Clinics (2017-2022) & ($ Millions)
    Figure 11. Colorectal Cancer Diagnostics & Therapeutics in Others
    Figure 12. Global Colorectal Cancer Diagnostics & Therapeutics Market: Others (2017-2022) & ($ Millions)
    Figure 13. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application in 2021
    Figure 14. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Player in 2021
    Figure 15. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Regions (2017-2022)
    Figure 16. Americas Colorectal Cancer Diagnostics & Therapeutics Market Size 2017-2022 ($ Millions)
    Figure 17. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size 2017-2022 ($ Millions)
    Figure 18. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size 2017-2022 ($ Millions)
    Figure 19. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size 2017-2022 ($ Millions)
    Figure 20. Americas Colorectal Cancer Diagnostics & Therapeutics Value Market Share by Country in 2021
    Figure 21. Americas Colorectal Cancer Diagnostics & Therapeutics Consumption Market Share by Type in 2021
    Figure 22. Americas Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application in 2021
    Figure 23. United States Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Canada Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 25. Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 27. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Region in 2021
    Figure 28. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application in 2021
    Figure 29. China Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Japan Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Korea Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 33. India Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Australia Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Country in 2021
    Figure 36. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type in 2021
    Figure 37. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application in 2021
    Figure 38. Germany Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 39. France Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 40. UK Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Italy Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Russia Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Region in 2021
    Figure 44. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type in 2021
    Figure 45. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application in 2021
    Figure 46. Egypt Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 47. South Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Israel Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 50. GCC Country Colorectal Cancer Diagnostics & Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Americas Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 52. APAC Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 53. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 54. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 55. United States Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 56. Canada Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 57. Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 58. Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 59. China Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 60. Japan Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 61. Korea Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 62. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 63. India Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 64. Australia Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 65. Germany Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 66. France Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 67. UK Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 68. Italy Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 69. Russia Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 70. Spain Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 71. Egypt Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 72. South Africa Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 73. Israel Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 74. Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 75. GCC Countries Colorectal Cancer Diagnostics & Therapeutics Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Colorectal Cancer Diagnostics & Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Colorectal Cancer Diagnostics & Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Colorectal Cancer Diagnostics & Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports